New hope for IBD patients: IL-23 drugs under Real-World study in china
NCT ID NCT07184138
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study looks at how well IL-23 inhibitors work for people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) in China. About 178 adults will receive these drugs in regular clinic settings, and researchers will check if symptoms go away and if the bowel heals after 52 weeks. The goal is to see if these treatments are effective and safe for Chinese patients in everyday practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.